Progress in the research on venous thromboembolism

Abstract

Venous thromboembolism (VTE) is a common disease with high risk for death and recurrence and can severely impair patients’ quality of life. Despite decades of study on this troublesome disease, there are still many unsolved problems in terms of pathogenesis, diagnosis and treatment. Hundreds of articles with various study methods and controversial research results are published every year. Thus it is crucial to keep track of reliable recent studies and articles on VTE in order to better understand it and to handle intricate related clinical events more reasonably. We reviewed high-qualified articles and guidelines from recent years and summarized VTE-related progresses in this review.

Keywords

venous thromboembolism / pulmonary embolism / deep vein thrombosis

References

[1] DeitelzweigSB, JohnsonBH, LinJ, et al. . Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol, 2011, 86(2): 217-220 PMID: 21264912

[2] LiewNC, AlemanyGV, AngchaisuksiriP, et al. . Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Int Angiol, 2017, 36(1): 1-20 PMID: 27606807

[3] HuangW, GoldbergRJ, AndersonFA, et al. . Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med, 2014, 127(9): 829-839 PMID: 24813864 PMCID: 4161646

[4] ArshadN, IsaksenT, HansenJB, et al. . Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol, 2017, 32(4): 299-305 PMID: 28314981

[5] KamerkarDR, JohnMJ, DesaiSC, et al. . Arrive: A retrospective registry of Indian patients with venous thromboembolism. Indian J Crit Care Med, 2016, 20(3): 150-158 PMID: 27076726 PMCID: 4810892

[6] AlotaibiGS, WuC, SenthilselvanA, et al. . Secular trends in incidence and mortality of acute venous thromboembolism: The AB-VTE population-based study. Am J Med, 2016, 129(8): 879 PMID: 26925811

[7] CohenAT, AgnelliG, AndersonFA, et al. . Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost, 2007, 98(4): 756-764 PMID: 17938798

[8] AndresenMS, SandvenI, BrunborgC, et al. . Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy. Thromb Res, 2011, 127(6): 540-546 PMID: 21435698

[9] JanataK, HolzerM, DomanovitsH, et al. . Mortality of patients with pulmonary embolism. Wien Klin Wochenschr, 2002, 114(17-18): 766-772 PMID: 12416281

[10] BarsoumMK, HeitJA, AshraniAA, et al. . Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res, 2010, 126(5): 373-378 PMID: 20833412 PMCID: 2975753

[11] HeitJA, SilversteinMD, MohrDN, et al. . Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med, 2000, 160(6): 809-815 PMID: 10737280

[12] CushmanM, FolsomAR, WangL, et al. . Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood, 2003, 101(4): 1243-1248 PMID: 12393393

[13] SmeethL, CookC, ThomasS, et al. . Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 2006, 367(9516): 1075-1079 PMID: 16581406

[14] BezemerID, van der MeerFJ, EikenboomJC, et al. . The value of family history as a risk indicator for venous thrombosis. Arch Intern Med, 2009, 169(6): 610-615 PMID: 19307525

[15] CannegieterSC, Horvath-PuhoE, SchmidtM. Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study. Blood, 2015, 125(2): 229-235 PMID: 25398934

[16] SweetlandS, GreenJ, LiuB, et al. . Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ, 2009, 339: b4583 PMID: 19959589 PMCID: 2788913

[17] SweetlandS, ParkinL, BalkwillA, et al. . Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. Circulation, 2013, 127(12): 1276-1282 PMID: 23481621

[18] SamamaMM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med, 2000, 160(22): 3415-3420 PMID: 11112234

[19] KaplanD, CasperTC, ElliottCG, et al. . VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest, 2015, 148(5): 1224-1230 PMID: 26111103 PMCID: 4631038

[20] OgdieA, Kay McGillN, ShinDB, et al. . Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general populationbased cohort study. Eur Heart J, 2017

[21] ChungW, SLinCL. Increased risks of venous thromboembolism in patients with psoriasis. A Nationwide Cohort Study. Thromb Haemost, 2017, 117(8): 1637-1643 PMID: 28536717

[22] LeeJJ, PopeJE. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases. Arthritis Res Ther, 2014, 16(5): 435 PMID: 25253302 PMCID: 4207310

[23] MahmoodiBK, CushmanM, Anne NaessI, et al. . Association of traditional cardiovascular risk factors with venous thromboembolism: An individual participant data meta-analysis of prospective studies. Circulation, 2017, 135(1): 7-16 PMID: 27831499

[24] TosettoA, MissiagliaE, FrezzatoM, et al. . The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost, 1999, 82(5): 1395-1398 PMID: 10595625

[25] ToulonP, PerezP, RappJ, et al. . An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities. Thromb Haemost, 2007, 98(1): 228-233 PMID: 17598017

[26] FolsomAR, CushmanM, TsaiMY, et al. . A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood, 2002, 99(8): 2720-2725 PMID: 11929758

[27] Alhenc-GelasM, NicaudV, GandrilleS, et al. . The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost, 1999, 81(2): 193-197 PMID: 10063990

[28] BorgelD, RenyJL, FischelisD, et al. . Cleaved protein S (PS), total PS, free PS, and activated protein C cofactor activity as risk factors for venous thromboembolism. Clin Chem, 2003, 49(4): 575-580 PMID: 12651809

[29] De StefanoV, SimioniP, RossiE, et al. . The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica, 2006, 91(5): 695-698 PMID: 16670075

[30] El-GalalyTC, SeverinsenMT, OvervadK, et al. . Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study. Br J Haematol, 2013, 160(6): 838-841 PMID: 23150947

[31] RoviteV, MaurinsU, MegnisK, et al. . Association of F11 polymorphism rs2289252 with deep vein thrombosis and related phenotypes in population of Latvia. Thromb Res, 2014, 134(3): 659-663 PMID: 25091233

[32] TregouetDA, HeathS, SautN, et al. . Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood, 2009, 113(21): 5298-5303 PMID: 19278955

[33] TangL, HuY. Ethnic diversity in the genetics of venous thromboembolism. Thromb Haemost, 2015, 114(5): 901-909 PMID: 26156046

[34] HernandezW, GamazonER. Novel genetic predictors of venous thromboembolism risk in African Americans. Blood, 2016, 127(15): 1923-1929 PMID: 26888256 PMCID: 4832509

[35] KabrhelC, CamargoCAJr, GoldhaberSZ. Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter. Chest, 2005, 127(5): 1627-1630 PMID: 15888838

[36] DoumaRA, MosIC, ErkensPM, et al. . Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med, 2011, 154(11): 709-718 PMID: 21646554

[37] SchoutenHJ, GeersingGJ, KoekHL, et al. . Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ, 2013, 346: f2492 PMID: 23645857 PMCID: 3643284

[38] De MonyeW, SansonBJ, Mac GillavryMR, et al. . Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med, 2002, 165(3): 345-348 PMID: 11818319

[39] EhrmannS, QuartinA, HobbsBP, et al. . Contrastassociated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med, 2017, 43(6): 785-794 PMID: 28197679

[40] WangX, SundquistK, ElfJL, et al. . Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis. Thromb Haemost, 2016, 116(2): 328-336 PMID: 27197074

[41] VossenCY, van Hylckama VliegA, Teruel-MontoyaR, et al. . Identification of coagulation gene 3'UTR variants that are potentially regulated by microRNAs. Br J Haematol, 2017, 177(5): 782-790 PMID: 28444748

[42] StarikovaI, JamalyS, SorrentinoA, et al. . Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals. Thromb Res, 2015, 136(3): 566-572 PMID: 26235746

[43] BruzeliusM, IglesiasMJ. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. Blood, 2016, 128(23): e59-e66 PMID: 27742707

[44] van der HulleT, KooimanJ, den ExterPL, et al. . Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost, 2014, 12(3): 320-328 PMID: 24330006

[45] KonstantinidesSV, VicautE, DanaysT, et al. . Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol, 2017, 69(12): 1536-1544 PMID: 28335835

[46] FanY, HuangH, XiongM, et al. . Comparison of efficacy of different treatments for pulmonary embolism. J Huazhong Univ Sci Technol [Med Sci], 2016, 36(2): 254-258

[47] MartiC, JohnG, KonstantinidesS, et al. . Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J, 2015, 36(10): 605-614 PMID: 24917641

[48] BashirR, ZackCJ, ZhaoH, et al. . Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs. anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. JAMA Intern Med, 2014, 174(9): 1494-1501 PMID: 25047081

[49] JarrettH, ZackCJ, AggarwalV, et al. . Impact of institutional volume on outcomes of catheter directed thrombolysis in the treatment of acute proximal deep vein thrombosis: A 6-year US experience (2005-2010). Circulation, 2015, 132(12): 1127-1135 PMID: 26199337